SenesTech, Inc. (NASDAQ:SNES) Sees Large Decrease in Short Interest

SenesTech, Inc. (NASDAQ:SNES) saw a significant decline in short interest during the month of July. As of July 15th, there was short interest totalling 42,200 shares, a decline of 90.7% from the June 30th total of 454,800 shares. Based on an average daily trading volume, of 10,800 shares, the short-interest ratio is presently 3.9 days. Currently, 0.8% of the company’s shares are short sold.

Institutional Trading of SenesTech

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC purchased a new stake in shares of SenesTech, Inc. (NASDAQ:SNES) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech at the end of the most recent reporting period. Institutional investors and hedge funds own 5.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on SNES. StockNews.com initiated coverage on SenesTech in a research note on Saturday, July 20th. They issued a “sell” rating for the company. HC Wainwright restated a “buy” rating and set a $35.00 price objective on shares of SenesTech in a research report on Tuesday, May 14th.

SenesTech Stock Performance

Shares of SNES stock traded down $0.26 during trading on Friday, hitting $4.57. 32,112 shares of the stock traded hands, compared to its average volume of 29,961. SenesTech has a 52-week low of $4.00 and a 52-week high of $115.20. The firm’s fifty day moving average price is $6.15 and its 200-day moving average price is $7.69. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03.

SenesTech (NASDAQ:SNES) last posted its earnings results on Thursday, May 9th. The company reported ($3.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.40) by ($0.20). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The business had revenue of $0.42 million for the quarter, compared to analyst estimates of $0.43 million. During the same period last year, the business earned ($158.50) EPS. Analysts anticipate that SenesTech will post -1.1 earnings per share for the current year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.